Marvel Medtech Advanced Manufacturing
Provides contract manufacturing for high-precision ceramic 3D printing using XJet NPJ technology, enabling features under 100 microns for medical and aerospace applications.
- CEO / Founder
- Raymond Harter
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $2.5M
- Latest Round
- Grant
- Key Investors
- National Cancer Institute/National Institutes of Health (NCI/NIH)
Technology & Products
Key Products
High-precision ceramics 3D printing services for medical and aerospace applications, featuring Zirconia and Alumina.
Technological Advantage
CLAIMED: High-precision ceramics with unprecedented accuracy and design flexibility. VERIFIED: Early adopter status of XJet NanoParticle Jetting (NPJ) technology in the US market.
Differentiation
Value Proposition
Enables the production of complex ceramic parts with 10-micron layers and features under 100 microns, reducing lead times and eliminating tooling costs for high-performance materials like zirconia and alumina.
How They Differentiate
Provides 10-micron layer resolution and features under 100 microns using XJet NPJ, offering higher precision and isotropic properties compared to traditional ceramic molding or machining.
Market & Competition
Target Customers
Industrial and medical OEMs requiring high-precision, complex ceramic components for prototyping or low-volume production.
Industry Verticals
Medical; Aerospace; Energy; Automotive
Competitors
XJet
Growth & Milestones
Growth Metrics
Revenue <$5 Million; employee growth data not specified.
Major Milestones
One of the first US companies to obtain XJet NPJ technology; Developed unique expertise in high-precision ceramic NPJ capabilities
Notable Customers
XJet (Development & Reference Partner); Marvel Medtech LLC (Internal Medical Device Division)